DNA damage response protein
Researchers at Vanderbilt University and Vanderbilt University Medical Center have determined that a previously uncharacterized protein called ETAA1 is a “replication stress response protein” with an essential role in maintaining the integrity of the genome.
The finding by David Cortez , Ph.D., Walter Chazin , Ph.D., and colleagues adds to the list of proteins known to be involved in DNA replication, the accurate copying of the genetic code each time a cell divides.
In particular, ETAA1 acts at stalled replication forks, where the double-helical DNA molecule splits apart and copies are made of each strand. The stalled replication fork has been compared to a paper jam in a copy machine. ETAA1 is one of a number of proteins that can undo the “jam.”
Quantity is important. Too much or too little of the protein is associated with DNA damage. Similarly, mutations in the ETAA1 gene are known to increase the risk for pancreatic cancer.
Original publication
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
Last viewed contents
Chempolis to supply three biorefineries to China
Genes against drought
Fierce competition between the human immune system and bacterial pathogens - New insights into the recent development of the human immune system
Merck off to a Good Start in Fiscal 2024 - The positive development of Healthcare and Electronics largely compensated for the decline in Life Science
'Tearless' onions could help in the fight against cardiovascular disease
Charles_McIlvaine
Agendia expands its business activities in Germany
Drägerwerk: Turnaround program already saved around EUR 45 million in 2009
Bacteria on marine sponges can develop capacity to move and inhibit biofilm formation
Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology - Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more than one billion USD upon successful achievement
